Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

INSYS THERAPEUTICS INC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Study to Compare Bioavailability of Naloxone Nasal Spray and Naloxone Hydrochloride (HCl) Intramuscular Injection (IM) in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy Volunteer

First Posted Date: 2019-02-01

Last Posted Date: 2019-02-01

Lead Sponsor: INSYS Therapeutics Inc

Target Recruit Count: 24

Registration Number: NCT03827629

Locations: 🇺🇸
Worldwide Clinical Trials, San Antonio, Texas, United States

A Study to Compare Bioavailability of Naloxone Nasal Spray, Naloxone Hydrochloride (HCl) Intravenous (IV) and Intramuscular Injection (IM) in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy Volunteer

First Posted Date: 2019-02-01

Last Posted Date: 2019-02-01

Lead Sponsor: INSYS Therapeutics Inc

Target Recruit Count: 24

Registration Number: NCT03827642

Locations: 🇺🇸
Worldwide Clinical Trials, San Antonio, Texas, United States

Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain

Phase 2

Completed

Conditions: Pain, Postoperative

Interventions: Drug: Buprenorphine Sublingual Spray
Drug: Morphine
Drug: Zofran
Drug: Oxycodone Hydrochloride

First Posted Date: 2017-08-18

Last Posted Date: 2018-10-29

Lead Sponsor: INSYS Therapeutics Inc

Target Recruit Count: 100

Registration Number: NCT03254459

Locations: 🇺🇸
Lotus Clinical Research, LLC, Pasadena, California, United States
🇺🇸
Epic Medical Research, Murray, Utah, United States

Fentanyl Sublingual Spray for the Treatment of Moderate to Severe Post-Operative Pain

Phase 2

Completed

Conditions: Pain

Interventions: Drug: Placebo
Drug: Fentanyl

First Posted Date: 2016-09-27

Last Posted Date: 2018-02-14

Lead Sponsor: INSYS Therapeutics Inc

Target Recruit Count: 45

Registration Number: NCT02915978

Locations: 🇺🇸
Arizona Research Center, Phoenix, Arizona, United States
🇺🇸
Anaheim Clinical Trials, Anaheim, California, United States

Fentanyl Sublingual Spray in Opioid Naive Participants

Phase 1

Completed

Conditions: Pharmacology

Interventions: Drug: Fentanyl Sublingual Spray
Drug: Fentanyl Citrate IV

First Posted Date: 2015-12-29

Last Posted Date: 2016-03-30

Lead Sponsor: INSYS Therapeutics Inc

Target Recruit Count: 96

Registration Number: NCT02641340

Locations: 🇺🇸
Lotus Clinical Research, Inc., Pasadena, California, United States

Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain

Phase 3

Completed

Conditions: Pain

Interventions: Drug: Placebo
Drug: Buprenorphine

First Posted Date: 2015-12-18

Last Posted Date: 2017-08-14

Lead Sponsor: INSYS Therapeutics Inc

Target Recruit Count: 322

Registration Number: NCT02634788

Locations: 🇺🇸
Arizona Research Center, Phoenix, Arizona, United States
🇺🇸
Anaheim Clinical Trials, Anaheim, California, United States
🇺🇸
Chesapeake Research Group, Pasadena, Maryland, United States

and more 1 locations

Comparative Bioavailability of Dronabinol Oral Solution in Healthy Volunteers

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Treatment A
Drug: Treatment B
Drug: Treatment C

First Posted Date: 2015-11-16

Last Posted Date: 2016-01-20

Lead Sponsor: INSYS Therapeutics Inc

Target Recruit Count: 54

Registration Number: NCT02604992

Locations: 🇺🇸
Worldwide Clinical Trials Early Phase Services, LLC, San Antonio, Texas, United States

Fentanyl Sublingual Spray and Fentanyl Citrate Intravenous (IV) in Opioid Naive Subjects

Phase 1

Completed

Conditions: Pharmacokinetics and Pharmacodynamics

Interventions: Drug: Fentanyl
Drug: Fentanyl Citrate

First Posted Date: 2015-10-15

Last Posted Date: 2015-12-02

Lead Sponsor: INSYS Therapeutics Inc

Target Recruit Count: 50

Registration Number: NCT02576353

Locations: 🇺🇸
Lotus Clinical Research, Pasadena, California, United States

Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms

Phase 2

Terminated

Conditions: Spasms, Infantile

Interventions: Drug: Cannabidiol Oral Solution

First Posted Date: 2015-09-16

Last Posted Date: 2018-09-19

Lead Sponsor: INSYS Therapeutics Inc

Target Recruit Count: 9

Registration Number: NCT02551731

Locations: 🇺🇸
Mattel Children's Hospital at UCLA, Los Angeles, California, United States
🇺🇸
University of California - San Francisco, San Francisco, California, United States
🇺🇸
Miami Children's Hospital, Miami, Florida, United States

and more 1 locations

Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers

Phase 1

Completed

Conditions: Opiate Dependence

Interventions: Drug: SL spray
Drug: SL film

First Posted Date: 2015-06-22

Last Posted Date: 2015-09-03

Lead Sponsor: INSYS Therapeutics Inc

Target Recruit Count: 47

Registration Number: NCT02477267

Locations: 🇺🇸
Worldwide Clinical Trials Early Phase Services, LLC, San Antonio, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy